Canada: Convergence And Divergence On Securities Class Actions

The United States Supreme Court takes a new approach on the standards for certification.

The class action is a litigation technique that lends itself well to claims by security-holders against issuers. The classes of purchasers of securities are easily definable, the losses are often all too publicly ascertainable, and the procedural benefits of one large claim (as opposed to a multitude of related actions in various jurisdictions) are clear. Securities class actions can grow, geographically, depending on where the securities were issued. With increased integration of the Canadian and global (particularly American) capital markets, more and larger class action claims by disgruntled shareholders and bondholders can be expected.

Against this backdrop, a key pronouncement has been made by The United States Supreme Court in the much-publicized Amgen Inc. et al. v. Connecticut Retirement Plans and Trust Funds1 ("Amgen") decision, handed down on February 27, 2013. The court found that proof of materiality is not a prerequisite to certification of a securities class action. This is a significant development, opening the door in the United States to yet greater potential liability for capital markets participants. The decision in the Amgen case gives us cause to examine the regime for certifying securities class actions in both countries. The significance of certification cannot be underestimated.

Materiality Matters

Most securities lawsuits are based in fraudulent or negligent misrepresentation – the typical scenario is that either the offering documents or the continuous disclosure is alleged to be, by misstatement or omission, incorrect; therefore, the purchaser of the security relied on wrong information when buying or selling, and the issuer is consequently liable for value or opportunity lost.

Materiality is connected to the idea of reliance. For liability to arise, the plaintiff has to prove that they actually relied upon (as in, cared about) the wrong information when making a purchase. At its extremes, reliance is easy to understand. Some parts of the offering or disclosure documents (for example, financial statements) are obviously important. Other parts (the spelling of the surname of the chair of the Audit Committee) are clearly irrelevant, or immaterial, to whether a purchaser will want to buy the securities. Between these extremes, one finds the majority of the documents at issue and a vast grey area of potential reliance, depending both on the nature of the issuer and the nature of the buyer.

The Supreme Court of Canada wisely chose, in the 2011 decision in Sharbern Holding Inc. v. Vancouver Airport Centre Ltd.2 ("Sharbern") to inculcate a "reasonable investor" test in Canadian securities law. The Sharbern case is discussed here in detail. A statement is "material" if the information in question would matter (i.e., be relied upon) to the reasonable, hypothetical investor when considering the investment. Whether or not the investor actually relied on the information is not considered in the "reasonable investor" test.

This benefits everybody: the investor does not have to establish their particular reliance, which can be complex from an evidentiary standpoint; the issuer is not beset by bizarre investors who purport to care about minutia.

Class Proceedings

Class actions feature an early stage, known as "certification", in which the court blesses the class claim as legitimate and as an appropriate means of conduct. Fighting certification can be a worthwhile tactic for the issuer, particularly if the individual plaintiffs lack the means to act on their own accord.

In Ontario, the test for certification is set out in section 5(1) of the Class Proceedings Act.3 A significant part of that test is that "the claims or defences of the class members raise common issues". The "common issues" requirement is a feature of US law and is the plank on which an absence of materiality could lead to the class remaining uncertified. In short, from the plaintiff's perspective, there is no such thing as "collective reliance" – either each plaintiff relied on the false information, or they did not. A class composed of individuals who might and might not have relied on the information is not a class with common issues to try in court.

In Canada, one might think that Sharbern delivered a form of "collective reliance" to the benefit of plaintiffs in a class action. With the "reasonable investor" test, the plaintiffs need not worry about their own individual reliance situation. The law is confused, however, thanks to the more recent decision of the Ontario Superior Court of Justice in Green v. Canadian Imperial Bank of Commerce4 ("Green"). In Green, the court denied certification of a class action by CIBC shareholders based on the bank's exposure to the subprime crisis. The court in Green accepts that Sharbern "re-affirms the need to establish reliance in a common law misrepresentation claim", but misapplies the reasonable investor test by looking for individual reliance, which cannot be established on a class-wide basis.5

As an aside, the proposed representative plaintiffs in Green might give rise to second thoughts on the merits of the reasonable investor test. Mr. Green was an aficionado of share certificates. The disclosure of CIBC was hardly a factor when deciding whether to add a CIBC share certificate to his collection. The other representative plaintiff, a Mrs. Bell, invested through her husband, leaving the whole task to him. She was therefore totally unaware of what CIBC had disclosed.

The Amgen Decision

Amgen is a biotechnology company. The plaintiffs, a consortium of six state pension and nine state trust funds in Connecticut, alleged that Amgen misrepresented the safety of two anemia drugs it was producing. Clinical trials may have suggested that the drugs could harm cancer patients. The FDA expressed concern about the drugs' use, causing a 9% drop in Amgen's share price.

In the United States, s. 10(b) of the Securities Exchange Act of 19346 with SEC Rule 10b-57 creates a plaintiff-side obligation to establish reliance; i.e. each purchaser of securities must show they relied on the misrepresentation in question to have a claim against the issuer. As stated above, this is a difficult evidentiary challenge for a potential plaintiff.

The United States Supreme Court created an avenue to avoid that burden in the form of the "fraud on the market" theory of loss. The concept, as described by Justice Blackmun in Basic Inc. v. Levinson8 ("Levinson"), is that the price of a security is a function of the company and its business. Misleading statements therefore have the effect of defrauding purchasers of the delta between the "true" and "fraudulent" share value, regardless of reliance. The fraud on the market theory requires the securities to be traded in an efficient market and that the misrepresentation in question was made publicly. Reliance is not discharged by pleading the fraud on the market theory; rather, it is presumed and demonstrated objectively – a "reasonable investor" standard much like Sharbern.

Amgen is a "fraud on the market" ("FOTM") case. The United States Supreme Court, in a 6-3 decision written by Justice Ginsberg, found that, as materiality in fraud on the market situations is evaluated according to an objective standard, there can be no doubt that the degree of materiality of Amgen's misrepresentations on the anemia drugs is a common question to all class members. Either the reliance is objectively reasonable, or it isn't; the particular degrees of concern of each class member/investor are irrelevant. Amgen, thanks to the alignment of the fraud on the market theory and the reasonable investor test, clarifies the class certification requirement.


The courts in Canada have rejected the fraud on the market theory. The most high profile case touching on this issue is Carom v. Bre-X Minerals Ltd.,9 in which the court in Ontario suggests the fraud on the market theory springs from the particular statutory context in which it originated, i.e. the restrictions in Rule 10b-5. This is, arguably, precisely not what the court was seeking to achieve in Levinson. The fraud on the market theory is as much a workaround as a statutory construct. Despite this misunderstanding, it doesn't exist here.

The absence of fraud on the market in Canada was noted by the court in Green,10 and might be suggested by some as the reason why Amgen is irrelevant in this jurisdiction. This viewpoint would not be accurate. The fraud on the market theory is the device by which the materiality standards in Canada and the United States happen to align. The aims of both courts, we speculate, in both Sharbern and Levinson were the same – to give comfort on what degree of misrepresentation opens the doors to a lawsuit.

Finally, we are not completely without the effect of the fraud on the market theory in Canada. The court in Green observes that s. 138.3 of the Ontario Securities Act,11 (and its equivalents in other provinces) which creates a right of action for misrepresentations operating on secondary market participants, was enacted in part to compensate for the absence of the fraud on the market theory in this country.

Squaring Sharbern and Green so the Result is Amgen

One possible way for the Green and Sharbern decisions to co-exist without confusion would be to have both an objective and subjective test of reliance. The test would have two stages: first, the court would ask if the misrepresentation at issue is one that would concern the reasonable investor (the objective test). If the court found the misrepresentation to be material to the reasonable investor, it would then ask if the actual investors/plaintiffs in fact relied on the misrepresentation. The two-stage test can be summarized by asking "was the plaintiffs' reliance reasonable?" On the court's reasoning in Green, there would still be no class action certification as long as any part of the materiality test is subjective.

There are two problems with this two-stage test: one, this was emphatically not what was prescribed in Sharbern, which was both a class action and a decision of the highest court in Canada; and two, this type of test does nothing to encourage accurate disclosure, as it further removes the plaintiffs from being able to sue when the disclosure is faulty.

Another way of squaring the Green and Sharbern decisions would be to ignore the substance of Green and accept the procedure. The result of this approach would be that materiality remains a burden on the plaintiffs at the certification stage of a class action, but the test would be an objective one. The natural evolution from this position is Amgen: if the materiality standard is the same for each investor, and is analyzed objectively, it is a common issue for all investors and would not foil the approval of a class.

The Significance of Amgen for Canadians

Although the Canadian courts need not, and should not, devote much thought to the class action certification procedure in the United States, it is of general concern that dramatic differences do not arise between the process there and here. The United States Supreme Court reached a common-sense decision in Amgen; we would benefit in Canada from evolving our position in that direction.

The United States Supreme Court's decision also heralds the prospect of yet more securities class actions succeeding in certification there (and consequently, more such actions being started, at least, here, if the securities were also issued into Canada). Although materiality will still need to be proven at the trial of a claim, dropping the examination of the question at the certification stage removes a barrier for plaintiffs seeking to press forward to a settlement. The truth of all class action litigation is that settlement for business or economic reasons, regardless of the merits of the case, is a likely outcome. Class actions are expensive and often damaging to public and investor relations. Fighting certification, from the issuer's standpoint, can be tantamount to fighting the whole case.

If you have any questions concerning this bulletin, please contact the authors or any member of the Davis Litigation Group.


1 No. 11-1085,—S. Ct (US)

2 [2011] 2 S.C.R. 175

3 S.O. 1992, c. 6

4 2012 ONSC 3637

5 Green, at para. 600

6 15 U.S.C. § 78a et seq.

7 17 C.F.R. 240 10b-5

8 485 U.S. 224 (1988)

9 (1998) 41 O.R. (3d) 780

10 Green, at para. 595

11 R.S.O. 1990, c. S.5

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.